Paper8290476
Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrine oxazolidines.
Qiu Y and 2 others. Pharm Res, 1993. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrine oxazolidines. Papers, record 8290476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8290476
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrine oxazolidines.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Eye | Major topic |
| Oxazoles | Major topic |
| Phenylephrine | Major topic |
| Animals | |
| Biological Availability | |
| Chromatography, High Pressure Liquid | |
| Drug Stability | |
| Female | |
| Male | |
| Ophthalmic Solutions | |
| Rabbits | |
| Solubility |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3427210 | Ophthalmic bioequivalence of steroid/antibiotic combination formulations. | Biopharm Drug Dispos | 1987 | https://conductscience.org/library/papers/3427210 | PubMed |
| 2 | 4705686 | Dissolution profile of log-normal powders: exact expression. | J Pharm Sci | 1973 | https://conductscience.org/library/papers/4705686 | PubMed |
| 3 | 5059787 | Dissolution rate patterns of log-normally distributed powders. | J Pharm Sci | 1972 | https://conductscience.org/library/papers/5059787 | PubMed |
| 4 | 8272415 | Physicochemical characterization of high- and low-melting phenylephrine oxazolidines. | Pharm Res | 1993 | https://conductscience.org/library/papers/8272415 | PubMed |
| 5 | 2182264 | Ocular drug delivery. Pharmacokinetic considerations. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2182264 | PubMed |
| 6 | 20491 | Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine. | J Pharm Sci | 1977 | https://conductscience.org/library/papers/20491 | PubMed |
| 7 | 22603 | Estimation of the degree of crystallinity in digoxin by X-ray and infrared methods. | J Pharm Pharmacol | 1977 | https://conductscience.org/library/papers/22603 | PubMed |
| 8 | 2367315 | Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes. | Pharm Res | 1990 | https://conductscience.org/library/papers/2367315 | PubMed |
| 9 | 1133744 | Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone. | J Pharm Sci | 1975 | https://conductscience.org/library/papers/1133744 | PubMed |
| 10 | 512850 | Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications. | J Pharm Sci | 1979 | https://conductscience.org/library/papers/512850 | PubMed |
| 11 | 4397454 | Aspirin dissolution: polymorphism, crystal habit or crystal defects. | J Pharm Pharmacol | 1971 | https://conductscience.org/library/papers/4397454 | PubMed |
| 12 | 13954439 | Dissolution rates of finely divided drug powders. II. Micronized methyl-prednisolone. | J Pharm Sci | 1963 | https://conductscience.org/library/papers/13954439 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8290476
GET https://conductscience.org/api/papers/v1/8290476/authors